go back

Diphenhydramine, Oral

Vermont rates for HCPCS Q0163

Diphenhydramine HCl, 50 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at time of chemotherapy treatment not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $2 · 10th–90th $2$20%50%100%$2Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.1$0.1$0.2$0.5$1.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.11
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.18
Median
$0.28
Typical High
$0.28
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.04
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$0.18
Median
$0.18
Typical High
$0.18
United
Setting
Facility
Modifier
Global
Typical Low
$1.62
Median
$1.62
Typical High
$1.62
United
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.28